Crossmark

Long term treatment with omalizumab in adolescent with refractory solar urticaria

Published Online: 2021-09-28

Published Print: 2021-12

Authors

Iannelli, Mauro

Passanisi, Stefano

Crisafulli, Giuseppe

Arasi, Stefania

Caminiti, Lucia

Zirilli, Giuseppina

Pajno, Giovanni B. https://orcid.org/0000-0002-6897-4587
License Information

Text and Data Mining valid from 2021-09-28

Version of Record valid from 2021-09-28
More Information

Article History

Received: 12 July 2021

Accepted: 13 September 2021

First Online: 28 September 2021

Declarations

:

: Not applicable.

: Written informed consent was obtained from the patient’s parents for the publication of this case report.

: The authors declare that they have no competing interests.

Document is current